Elizabeth Warren Calls for an Insider Trading Inquiry at the Fed

The Democratic senator responded to news that the Fed’s vice chair shifted toward stocks shortly before a policy announcement last year.

Goldman Sachs, Ozy Media and a $40 Million Conference Call Gone Wrong

The digital media company has raised eyebrows for its claims about its audience size for years. Then came the strange voice on the phone.

Phony Walmart News Release Signals a Crypto Pump-and-Dump Scheme

Digital currencies briefly jumped in value after a fake release said the retailer would start accepting the little-used Litecoin.

Phony Walmart News Release Signals a Crypto Pump-and-Dump Scheme

Digital currencies briefly jumped in value after a fake release said the retailer would start accepting the little-used Litecoin.

Google Could Be Violating Labor Laws With Pay for Temp Workers

The company realized months ago that it could be running afoul of pay laws in a number of countries but has been slow to fix the problem, according to internal documents.

Schemer or Naïf? Elizabeth Holmes Is Going to Trial.

The trial for the founder of Theranos, the once high-flying blood testing start-up, will cap a saga of Silicon Valley hubris, ambition and deception.

A Skeptical Stock Analyst Wins Big by Seeking Out Frauds

The activist short-seller behind Hindenburg Research has become known for research that sends companies’ stock sinking. He says he’s not in it just to move share prices.

U.S. Sells One-of-a-Kind Wu-Tang Album to Cover Martin Shkreli’s Debt

Prosecutors did not announce who purchased the album, or for how much, but a lawyer for Mr. Shkreli said the sale price appeared to be at least $2.2 million.

What if Inflation Isn’t ‘Transitory’?

More experts think higher prices will stay for a while.

Biotech Company That Botched Vaccines Faces Investor Revolt

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’...

Biotech Company That Botched Vaccines Faces Investor Revolt

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’...

Supreme Court Gives Goldman Sachs a Do-Over in Securities Fraud Suit

The justices said the bank may renew its arguments that its statements about honesty and integrity were too generic to support a class action for billions of dollars.